Maersk starts moving empty containers south to nervous exporters as supply chain troubles get an industry airing
16 Mar, 2021 04:34 AM
4 minutes to read
Tauranga first and last calls for first rotation in new container shipping service. Photo / Supplied New Zealand s acute container shortage should start easing a little soon as a new Maersk shipping service loads hundreds of empty containers at the Ports of Auckland, bound for anxious exporters in the South Island.
The container vessel the Seaspan Hannover is one of two ships on the new Sirius Star service, which will bring international imports, including refrigerated containers, picked up in Southeast Asia to New Zealand and move empty containers to South Island ports.
Married at First Sight
Red Arrow Studios International has secured a new deal with A+E Networks Asia for
Married at First Sight, which will see the dating format made available in Korea and Japan for the first time.
The company has also inked a further wave of international deals for the show including tape sales, local commissions and series recommissions.
For its pan-regional feed, A+E Networks Asia picked up tapes of the sixth season of
Married at First Sight Australia (pictured), produced by Endemol Shine Australia for Nine, as well as season six of the U.S. version, which is produced by Red Arrow Studios company Kinetic Content for Lifetime.
Amazon Studios Europe is looking to grow its team with a head of UK originals.
The executive would report to Georgia Brown (pictured), head of EU Originals, and be responsible for managing teams across all genres.
Last month, it was announced that former Channel 4 commissioner Fozia Khan would be joining the studio’s unscripted team, reporting to head of unscripted Dan Grabiner.
Amazon Prime Video UK’s unscripted lineup in the region includes such series as
The Grand Tour and
With a remit to support the growth of the streamer in the UK, qualifications include experience in building and managing content teams across development and production.
Published: Mar 16, 2021
Phase 2 AFFINITY Trial of Atrasentan for Patients with Glomerular Diseases Also on Track to Begin Enrollment in the First Half of 2021
VANCOUVER, British Columbia and SEATTLE, March 16, 2021 (GLOBE NEWSWIRE) Chinook Therapeutics, Inc.. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that the first patient with IgA nephropathy (IgAN) has been enrolled in the ALIGN Study, a pivotal phase 3 clinical trial evaluating the efficacy and safety of atrasentan, a potent and selective inhibitor of the endothelin A receptor.
“The initiation of the phase 3 ALIGN Study is an important milestone for Chinook as we advance our pipeline of programs for rare, severe chronic kidney diseases,” said Alan Glicklich, M.D., chief medical officer of Chinook. “Atrasentan has been studied in over 5,300 diabetic kidney disease patients in the phase 2 RADAR an